NEW YORK (Reuters Health) – As a treatment for early multiple sclerosis, alemtuzumab, an antibody that targets CD52 on lymphocytes and monocytes, is more effective than interferon beta-1a,…
NEW YORK (Reuters Health) – Encephalitis caused by human herpesviruses may trigger acute retinal necrosis, even years after the initial illness, Dutch investigators report in the October 14…
NEW YORK (Reuters Health) – Following transcatheter closure of a patent foramen ovale (PFO), migraine relief may occur despite residual right-to-left shunt, researchers report in the October 1st…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
NEW YORK (Reuters Health) – Patients aged 75 years and older with brain metastases respond about as well as younger patients to stereotactic radiosurgery (SRS), according to a…
NEW YORK (Reuters Health) – Even in the absence of clinical stroke, atrial fibrillation (AF) is associated with impaired cognitive function and reduced hippocampal volume, according to findings…
NEW YORK (Reuters Health) – With the introduction of more intensive medical therapy, revascularization for asymptomatic carotid stenosis is likely to benefit less than 5% of patients, according…
NEW YORK (Reuters Health) – Alteplase can improve stroke outcomes even when it is not given until 3 to 4.5 hours after the stroke began, according to a…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…